Evidence map›Paper›PMID 39582027›Full record

ArticlePneumonia (Nathan Qld.)2024

Community versus academic hospital community-acquired pneumonia patients: a nested cohort study.

Jennifer L Y Tsang, Kian Rego, Alexandra Binnie, Terry Lee, Anne Mccarthy, Juthaporn Cowan, Patrick Archambault, Francois Lellouche, Alexis F Turgeon, Jennifer Yoon and 19 more

Abstract read
In one paragraph

Article in Pneumonia (Nathan Qld.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jennifer L Y TsangNiagara Health Knowledge Institute, Niagara Health, St Catharines, ON, Canada.
Kian RegoNiagara Health Knowledge Institute, Niagara Health, St Catharines, ON, Canada.
Alexandra BinnieCritical Care Department, William Osler Health System, Brampton, ON, Canada.
Terry LeeCentre for Advancing Health Outcomes, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Anne MccarthyOttawa Research Institute, University of Ottawa, Ottawa, ON, Canada.
Juthaporn CowanOttawa Research Institute, University of Ottawa, Ottawa, ON, Canada.
Patrick ArchambaultCentre de recherche intégrée pour un système apprenant en santé et services sociaux, Centre intégré de santé et services sociaux de Chaudière-Appalaches, Levis, Québec, Canada.
Francois LelloucheDépartement de médecine, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec City, QC, Canada.
Alexis F TurgeonDivision of Critical Care Medicine, Faculty of Medicine, CHU de Québec-Université Laval Research Center, Population Health and Optimal Health Practices Unit, Trauma- Emergency- Critical Care Medicine, and Department of Anesthesiology and Critical Care Medicine, Université Laval, Québec City, QC, Canada.
Jennifer YoonHumber River Hospital, Toronto, ON, Canada.
Francois LamontagneUniversity of Sherbrooke, Sherbrooke, QC, Canada.
Allison McgeerMount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Josh DouglasLion's Gate Hospital, North Vancouver, BC, Canada.
Peter DaleyMemorial University of Newfoundland, St. John's, NL, Canada.
Robert FowlerSunnybrook Health Sciences Centre, Toronto, ON, Canada.
David M MasloveDepartment of Critical Care, Kingston General Hospital and Queen's University, Kingston, ON, Canada.
Brent W WinstonDepartments of Critical Care Medicine, Medicine and Biochemistry and Molecular Biology, Foothills Medical Centre, University of Calgary, Calgary, AB, Canada.
Todd C LeeDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Karen C TranDivision of General Internal Medicine, Vancouver General Hospital, Vancouver, BC, Canada.
Matthew P ChengDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Donald C VinhDivision of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
John H BoydCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Keith R WalleyCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Joel SingerCentre for Advancing Health Outcomes, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
John C MarshallDepartment of Surgery, St. Michael's Hospital, Toronto, ON, Canada.
Gregory HaljanDepartment of Medicine, Surrey Memorial Hospital, Surrey, BC, Canada.
Fagun JainBlack Tusk Research Group, Vancouver, BC, Canada.
James A RussellCentre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. Jim.Russell@hli.ubc.ca.
For CAPTIVATE Investigators

Funding

CIHR 439993
6 · The paper itself

Abstract

backgroundMost Canadians receive their care in community hospitals, yet most clinical research is conducted in academic hospitals. This study aims to compare patients with community acquired pneumonia (CAP) treated in academic and community hospitals with respect to their demographics, clinical characteristics, treatments and outcomes.

methodsThis nested observational cohort substudy of the Community Acquired Pneumonia: Toward InnoVAtive Treatment (CAPTIVATE) trial included 1,329 hospitalized adults with CAP recruited between March 1st, 2018 and September 31st, 2023 from 15 Canadian hospitals. Unadjusted and adjusted analyses for age, sex and co-morbidities using logistic, Cox and censored quantile regressions were conducted.

resultsPatients in community hospitals were older (mean [SD] 75.0 [15.7] years vs. 68.3 [16.2] years; p < 0.001), were more likely to be female (49.7% vs. 41.0%, p = 0.002), and had more comorbidities (75.9% vs. 64.8%, p < 0.001). More patients in community hospitals received corticosteroids (49.2% vs. 37.4%, p < 0.001). Community hospital patients had a higher likelihood of developing acute respiratory distress syndrome (OR 3.13, 95% CI: 1.87, 5.24, p = < 0.001), and acute cardiac injury (OR 2.53, 95% CI: 1.33, 4.83, p = 0.005). In unadjusted and adjusted analyses, 28-day mortality difference did not meet statistical significance (OR 1.43, 95% CI: 0.98, 20.7, p = 0.062 and OR 1.23, 95% CI: 0.81, 1.87, p = 0.332, respective).

conclusionPatients with CAP in Canadian community and academic hospitals differed with respect to their age, clinical characteristics, treatments and outcomes, emphasizing the importance of including more community hospitals in clinical research studies to ensure the generalizability of results.

Indexed as

Community-acquired pneumoniaCommunity hospitalCorticosteroidsMortality

Identifiers

PMID39582027
PMCPMC11587589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.